Brianna Norton, DO: Hepatitis C Treatment
OCTOBER 07, 2017
OCTOBER 07, 2017
Jenna Payesko
I think that really the majority the core of the Hep C epidemic is among people who use drugs. For a long time, the largest population was baby boomers and now because of the expanding opioid epidemic in the US there's actually a lot of younger people who are acquiring Hep C...
Transcript- http://www.mdmag.com/conference-coverage/idweek-2017/brianna-norton-do-hepatitis-c-treatment
Conference News
MD Magazine
Oct 4 - 8
NATAP Conference Coverage - ID Week
ID Week San Diego CA
October 4-8, 2017
Barriers to Hepatitis C Treatment in HIV co-infected Patients in the Era of New Direct-Acting Antiviral Therapy (Philadelphia): Just Over Half With HCV/HIV at Academic Center Get DAAs for HCV
Just over 50% of HCV/HIV-coinfected people in care at a Philadelphia academic center got treated for HCV with direct-acting antivirals (DAAs) in 2016 [1]. A detectable HIV load and substance abuse emerged as apparent barriers to DAA therapy.
View coverage - http://www.natap.org/2017/IDWeek/IDWeek.htm
NATAP Conference Coverage - ID Week
ID Week San Diego CA
October 4-8, 2017
Barriers to Hepatitis C Treatment in HIV co-infected Patients in the Era of New Direct-Acting Antiviral Therapy (Philadelphia): Just Over Half With HCV/HIV at Academic Center Get DAAs for HCV
Just over 50% of HCV/HIV-coinfected people in care at a Philadelphia academic center got treated for HCV with direct-acting antivirals (DAAs) in 2016 [1]. A detectable HIV load and substance abuse emerged as apparent barriers to DAA therapy.
View coverage - http://www.natap.org/2017/IDWeek/IDWeek.htm
No comments:
Post a Comment